UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Deciphering the complex interplay of obesity, epithelial barrier dysfunction, and tight junction remodeling: Unraveling potential therapeutic avenues

Obesity reviews, 2024-08, Vol.25 (8), p.e13766-n/a

2024

Volltextzugriff (PDF)

Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer

Biomedicine & pharmacotherapy, 2024-07, Vol.176, p.116873, Article 116873

2024

Volltextzugriff (PDF)

Molecular Analysis and Conformational Dynamics of Human MC4R Disease-Causing Mutations

Molecules (Basel, Switzerland), 2022-06, Vol.27 (13), p.4037

2022

Volltextzugriff (PDF)

Melanocortin‐4 receptor complexity in energy homeostasis,obesity and drug development strategies

Diabetes, obesity & metabolism, 2022-04, Vol.24 (4), p.583-598

2022

Volltextzugriff (PDF)

Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era

Journal of translational medicine, 2021-04, Vol.19 (1), p.137-137, Article 137

2021

Volltextzugriff (PDF)

A variant in sperm‐specific glycolytic enzyme enolase 4 (ENO4) causes human male infertility

The journal of gene medicine, 2024-01, Vol.26 (1), p.e3583-n/a

2024

Volltextzugriff (PDF)

Natural products as chemo-radiation therapy sensitizers in cancers

Biomedicine & pharmacotherapy, 2022-10, Vol.154, p.113610-113610, Article 113610

2022

Volltextzugriff (PDF)

Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans

Cell death discovery, 2024-05, Vol.10 (1), p.225-225, Article 225

2024

Volltextzugriff (PDF)

Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics

Journal of translational medicine, 2022-11, Vol.20 (1), p.534-534, Article 534

2022

Volltextzugriff (PDF)

A GHRHR founder mutation causes isolated growth hormone deficiency type IV in a consanguineous Pakistani family

Frontiers in endocrinology (Lausanne), 2023-03, Vol.14, p.1066182-1066182

2023

Volltextzugriff (PDF)

Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments

Journal of translational medicine, 2023-07, Vol.21 (1), p.449-449, Article 449

2023

Volltextzugriff (PDF)

Extracellular vesicles as tools and targets in therapy for diseases

Signal transduction and targeted therapy, 2024-02, Vol.9 (1), p.27-27, Article 27

2024

Volltextzugriff (PDF)

A Complex Intrachromosomal Rearrangement Disrupting IRF6 in a Family with Popliteal Pterygium and Van der Woude Syndromes

Genes, 2023-03, Vol.14 (4), p.849

2023

Volltextzugriff (PDF)

A de novo start-loss in EFTUD2 associated with mandibulofacial dysostosis with microcephaly: case report

Cold Spring Harbor molecular case studies, 2022-06, Vol.8 (4), p.a006206

2022

Volltextzugriff (PDF)

Epigenetic modifications: Key players in cancer heterogeneity and drug resistance

Translational oncology, 2024-01, Vol.39, p.101821-101821, Article 101821

2024

Volltextzugriff (PDF)

The role of dietary antioxidants in type 2 diabetes and neurodegenerative disorders: An assessment of the benefit profile

Heliyon, 2023-01, Vol.9 (1), p.e12698-e12698, Article e12698

2023

Volltextzugriff (PDF)

The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature

Journal of translational medicine, 2023-03, Vol.21 (1), p.171-171, Article 171

2023

Volltextzugriff (PDF)

Correction: Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments

Journal of translational medicine, 2023-08, Vol.21 (1), p.1-571, Article 571

2023

Volltextzugriff (PDF)

Ubiquitin specific peptidase 37 and PCNA interaction promotes osteosarcoma pathogenesis by modulating replication fork progression

Journal of translational medicine, 2023-04, Vol.21 (1), p.286-286, Article 286

2023

Volltextzugriff (PDF)

Validation of plasma protein glycation and oxidation biomarkers for the diagnosis of autism

Molecular psychiatry, 2024-03, Vol.29 (3), p.653-659

2024

Volltextzugriff (PDF)

Deep learning-based identification of esophageal cancer subtypes through analysis of high-resolution histopathology images

Frontiers in molecular biosciences, 2024-03, Vol.11, p.1346242-1346242

2024

Volltextzugriff (PDF)

Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression

Scientific reports, 2024-07, Vol.14 (1), p.15287-15, Article 15287

2024

Volltextzugriff (PDF)

Patterns and distribution of de novo mutations in multiplex Middle Eastern families

Journal of human genetics, 2022-10, Vol.67 (10), p.579-588

2022

Volltextzugriff (PDF)

Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance

Cancer and metastasis reviews, 2024-03, Vol.43 (1), p.197-228

2024

Volltextzugriff (PDF)

Current and emerging biomarkers in ovarian cancer diagnosis; CA125 and beyond

Advances in protein chemistry and structural biology, 2023, Vol.133, p.85-114

2023

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

PublikationsformBerichte

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(31)
Buchkapitel
(6)

Sprache

Englisch
(37)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Deciphering the complex interplay of obesity, epithelial barrier dysfunction, and tight junction remodeling: Unraveling potential therapeutic avenues

Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer

Molecular Analysis and Conformational Dynamics of Human MC4R Disease-Causing Mutations

Melanocortin‐4 receptor complexity in energy homeostasis,obesity and drug development strategies

Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era

A variant in sperm‐specific glycolytic enzyme enolase 4 (ENO4) causes human male infertility

Natural products as chemo-radiation therapy sensitizers in cancers

Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans

Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics

A GHRHR founder mutation causes isolated growth hormone deficiency type IV in a consanguineous Pakistani family

Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments

Extracellular vesicles as tools and targets in therapy for diseases

A Complex Intrachromosomal Rearrangement Disrupting IRF6 in a Family with Popliteal Pterygium and Van der Woude Syndromes

A de novo start-loss in EFTUD2 associated with mandibulofacial dysostosis with microcephaly: case report

Epigenetic modifications: Key players in cancer heterogeneity and drug resistance

The role of dietary antioxidants in type 2 diabetes and neurodegenerative disorders: An assessment of the benefit profile

The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature

Correction: Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments

Ubiquitin specific peptidase 37 and PCNA interaction promotes osteosarcoma pathogenesis by modulating replication fork progression

Validation of plasma protein glycation and oxidation biomarkers for the diagnosis of autism

Deep learning-based identification of esophageal cancer subtypes through analysis of high-resolution histopathology images

Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression

Patterns and distribution of de novo mutations in multiplex Middle Eastern families

Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance

Current and emerging biomarkers in ovarian cancer diagnosis; CA125 and beyond

Aktive Filter

Suchergebnisse filtern